Authors

Chris Thornham

Partner

Read More

Laurence Lieberman

Partner

Read More

Colin McCall

Partner

Read More
Authors

Chris Thornham

Partner

Read More

Laurence Lieberman

Partner

Read More

Colin McCall

Partner

Read More

31 October 2019 | 45:31

Arbitration: considerations for life science companies

In the second instalment of our Life Sciences Disputes webinar series, Arbitration: considerations for life science companies, we provide practical tips and advice, discuss key legislation and share case studies on how life sciences organisations can mitigate and manage their litigation risk.

Topics covered in the webinar include:

  • What subject matter can be arbitrated and how arbitration may arise?
  • Typical advantages/disadvantages of arbitration versus litigation.
  • Industry-specific points for parties in the life sciences considering arbitration.
  • Arbitration proceedings rules, tribunal composition, location and choice of law.
  • Decisions, remedies, enforcement and challenges
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

DNA helix
Life sciences & healthcare

Termination, force majeure and frustration – international perspectives on the life sciences sector

17 April 2020
QUICK READ

by multiple authors

Click here to find out more
International arbitration

Arbitration considerations for life science companies

29 September 2019

by multiple authors

Click here to find out more

Related events

There are no upcoming events